{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"7","upperLimit":"172","value":"30.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Number of days from beginning of orally administered lithium carbonate to the end of orally administered lithium carbonate","dispersionType":"Full Range","groups":[{"description":"Patients received oral lithium carbonate once or twice daily. Treatment continued for up to 8 weeks in the absence of disease progression or unacceptable toxicity.","id":"OG000","title":"Treated Patients"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Up to 6 months","title":"Duration of Treatment With the Study Product","type":"SECONDARY","unitOfMeasure":"days"}